Abstract
In rheumatoid arthritis (RA), T cells infiltrate into the synovial membrane where they initiate and maintain activation of macrophages and synovial fibroblasts, transforming them into tissue-destructive effector cells. The diversity of the disease process and the formation of complex lymphoid microstructures indicate that multiple T cell activation pathways are involved. This model is supported by the association of distinct disease patterns with different variants and combinations of HLA class II molecules. T cell pathology in RA, however, is not limited to the joint. Affected patients have major abnormalities in the T cell pool, with a marked contraction in T cell receptor diversity and an outgrowth of large clonal populations. Clonally expanded CD4+ T cells lose expression of the CD28 molecule and gain expression of perforin and granzyme. Consequently, the functional profile of expanded CD4+CD28null T cells is fundamentally changed and is shifted towards tissue-injurious capabilities. CD4+CD28null T cells are particularly important in patients with extra-articular manifestations of RA, where they may have a direct role in vascular injury. Understanding the mechanisms underlying the loss of T cell diversity and the emergence of pro-inflammatory CD4+CD28null T cell clonotypes may have implications for other autoimmune syndromes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Belghomari H., Saraux A., Allain J., Guedes C., Youinou P. and Le Goff P. (1999): Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis. J. Rheumatol., 26, 2534–2538.
Brett S., Baxter G., Cooper H., Johnston J. M., Tite J. and Rapson N. (1996): Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology, 88, 13–19.
Davis L. S. and Lipsky P. E. (1998): Disordered differentiation of memory T cells in rheumatoid arthritis. Rev. Rhum. Engl. Ed., 65, 291–296.
Finnegan A. and Schnitzer T. J. (1997): Persistence of CD4+ T cells in the arthritic joint after CAMPATH-1H treatment. J. Rheumatol., 24, 1448–1449.
Goronzy J. J., Bartz-Bazzanella P., Hu W., Jendro M. C., Walser-Kuntz D. R. and Weyand C. M. (1994): Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J. Clin. Invest., 94, 2068–2076.
Goronzy J. J. and Weyand C. M. (1993): Interplay of T lymphocytes and HLA-DR molecules in rheumatoid arthritis. Curr. Opin. Rheumatol., 5, 169–177.
Goronzy J. J. and Weyand C. M. (1995): T cells in rheumatoid arthritis. Paradigms and facts. Rheum. Dis. Clin. North Am., 21, 655–674.
Goronzy J. J., Zettl A. and Weyand C. M. (1998): T cell receptor repertoire in rheumatoid arthritis. Int. Rev. Immunol., 17, 339–363.
Harris E. D. (1997): Rheumatoid arthritis. W. B. Saunders Co., Philadelphia, 3–212.
Jendro M. C, Ganten T., Matteson E. L., Weyand C. M. and Goronzy J. J. (1995): Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum., 38, 1242–1251.
Kato T., Kurokawa M., Masuko-Hongo K., Sasakawa H., Sekine T., Ueda S., Yamamoto K. and Nishioka K. (1997): T cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T cell expansions. J. Immunol., 159, 5143–5149.
Klimiuk P. A., Goronzy J. J., Bjürnsson J., Beckenbaugh R. D. and Weyand C. M. (1997): Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am. J. Pathol., 151, 1311–1319.
Klimiuk P. A., Yang H., Goronzy J. J. and Weyand C. M. (1999): Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin. Immunol., 90, 65–78.
Kohem C. L., Brezinschek R. I., Wisbey H., Tortorella C., Lipsky P. E. and Oppenheimer-Marks N. (1996): Enrichment of differentiated CD45RBdim, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum., 39, 844–854.
Kurokawa M, Kato T., Masuko-Hongo K., Ueda S., Kobata T., Okubo M., Nishimaki T., Akaza T., Yoshino S., Kasukawa R., Nishioka K. and Yamamoto K. (1999): Characterisation of T cell clonotypes that accumulated in multiple joints of patients with rheumatoid arthritis. Ann. Rheum. Dis., 58, 546–553.
Liuzzo G., Goronzy J. J., Yang H., Kopecky S. L., Holmes D. R., Frye R. L. and Weyand C. M. (2000): Monoclonal T cell prolifertation and plaque instability in acute coronary syndromes. Circulation, 101, 2883–2888.
Liuzzo G., Kopecky S. L., Frye R. L., O’Fallon W. M., Maseri A., Goronzy J. J. and Weyand C. M. (1999): Perturbation of the T-cell repertoire in patients with unstable angina. Circulation, 100, 2135–2139.
Martens P. B., Goronzy J. J., Schaid D. and Weyand C. M. (1997): Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum., 40, 1106–1114.
Matteson E. L., Yocum D. E., St Clair E. W., Achkar A. A., Thakor M. S., Jacobs M. R., Hays A. E., Heitman C. K. and Johnston J. M. (1995): Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection. Arthritis Rheum., 38, 1187–1193.
Myllykangas-Luosujarvi R. A., Aho K. and Isomaki H. A. (1995): Mortality in rheumatoid arthritis. Semin. Arthritis Rheum., 25, 193–202.
Namekawa T., Wagner U. G., Goronzy J. J. and Weyand C. M. (1998): Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum., 41, 2108–2116.
Park W., Weyand C. M., Schmidt D. and Goronzy J. J. (1997): Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28− T cells. Eur. J. Immunol., 27, 1082–1090.
Rittner H. L., Zettl A., Jendro M. C, Bartz-Bazzanella P., Goronzy J. J. and Weyand C. M. (1997): Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis. Mol. Med., 3, 452–465.
Schirmer M., Vallejo A. N., Weyand C. M. and Goronzy J. J. (1998): Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J. Immunol., 161, 1018–1025.
Schmidt D., Goronzy J. J. and Weyand C. M. (1996a): CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest., 97, 2027–2037.
Schmidt D., Martens P. B., Weyand C. M. and Goronzy J. J. (1996b): The repertoire of CD4+ CD28− T cells in rheumatoid arthritis. Mol. Med., 2, 608–618.
Seldin M. F., Amos C. I., Ward R. and Gregersen P. K. (1999): The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum., 42, 1071–1079.
Symmons D. P., Jones M. A., Scott D. L. and Prior P. (1998): Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J. Rheumatol., 25, 1072–1077.
Turesson C., Jacobsson L. and Bergstrom U. (1999): Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford), 38, 668–674.
Vallejo A. N., Brandes J. C., Weyand C. M. and Goronzy J. J. (1999): Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J. Immunol., 162, 6572–6579.
Vallejo A. N., Nestel A. R., Schirmer M., Weyand C. M. and Goronzy J. J. (1998): Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J. Biol. Chem., 273, 8119–8129.
Waase I., Kayser C., Carlson P. J., Goronzy J. J. and Weyand C. M. (1996): Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum., 39, 904–913.
Wagner U. G., Koetz K., Weyand C. M. and Goronzy J. J. (1998a): Perturbation of the T cell repertoire in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 95, 14447–14452.
Wagner U. G., Kurtin P. J., Wahner A., Brackertz M., Berry D. J., Goronzy J. J. and Weyand C. M. (1998b): The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J. Immunol., 161, 6390–6397.
Walser-Kuntz D. R., Weyand C. M., Weaver A. J., O’Fallon W. M. and Goronzy J. J. (1995): Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity, 2, 597–605.
Weinblatt M. E., Maddison P. J., Bulpitt K. J., Hazleman B. L., Urowitz M. B., Sturrock R. D., Coblyn J. S., Maier A. L., Spreen W. R. and Manna V. K. (1995): CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. Arthritis Rheum., 38, 1589–1594.
Weyand C. M., Brandes J. C., Schmidt D., Fulbright J. W. and Goronzy J. J. (1998a): Functional properties of CD4+ CD28− T cells in the aging immune system. Mech. Ageing Dev., 102, 131–147.
Weyand C. M. and Goronzy J. J. (1994): HLA-DRB1 alleles as severity markers in RA. Bull. Rheum. Dis., 43, 5–8.
Weyand C. M. and Goronzy J. J. (1997a): Pathogenesis of rheumatoid arthritis. Med. Clin. North Am., 81, 29–55.
Weyand C. M. and Goronzy J. J. (1997b): The molecular basis of rheumatoid arthritis. J. Mol. Med., 75, 772–785.
Weyand C. M. and Goronzy J. J. (1999a): HLA polymorphisms and T cells in rheumatoid arthritis. Int. Rev. Immunol., 18, 37–59.
Weyand C. M. and Goronzy J. J. (1999b): T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease. Curr. Opin. Rheumatol., 11, 210–217.
Weyand C. M. and Goronzy J. J. (2000): HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res., 2, 212–216.
Weyand C. M., Hicok K. C., Conn D. L. and Goronzy J. J. (1992): The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med., 117, 801–806.
Weyand C. M., Klimiuk P. A. and Goronzy J. J. (1998b): Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin. Immunopathol., 20, 5–22.
Weyand C. M., McCarthy T. G. and Goronzy J. J. (1995): Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J. Clin. Invest., 95, 2120–2126.
Weyand C. M., Schmidt D., Wagner U. and Goronzy J. J. (1998c): The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum., 41, 817–822.
Winchester R. J. and Gregersen P. K. (1988): The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis. Springer Semin. Immunopathol., 10, 119–139.
Yang H., Rittner H., Weyand C. M. and Goronzy J. J. (1999): Aberrations in the primary T cell receptor repertoire as a predisposition for synovial inflammation in rheumatoid arthritis. J. Invest. Med., 47, 236–245.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weyand, C.M., Bryl, E., Goronzy, J.J. (2001). The Role of T Cells in Rheumatoid Arthritis. In: Górski, A., Krotkiewski, H., Zimecki, M. (eds) Autoimmunity. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0981-2_13
Download citation
DOI: https://doi.org/10.1007/978-94-010-0981-2_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3877-5
Online ISBN: 978-94-010-0981-2
eBook Packages: Springer Book Archive